@article{AbdelhameedHabibEltahawyetal.2020,
  author    = {Abdelhameed, Reda F. A. and Habib, Eman S. and Eltahawy, Nermeen A. and Hassanean, Hashim A. and Ibrahim, Amany K. and Mohammed, Anber F. and Fayez, Shaimaa and Hayallah, Alaa M. and Yamada, Koji and Behery, Fathy A. and Al-Sanea, Mohammad M. and Alzarea, Sami I. and Bringmann, Gerhard and Ahmed, Safwat A. and Abdelmohsen, Usama Ramadan},
  title     = {New cytotoxic natural products from the Red Sea sponge Stylissa carteri},
  series = {Marine Drugs},
  volume    = {18},
  journal   = {Marine Drugs},
  number    = {5},
  issn      = {1660-3397},
  doi       = {10.3390/md18050241},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-205795},
  year      = {2020},
  abstract  = {Bioactivity-guided isolation supported by LC-HRESIMS metabolic profiling led to the isolation of two new compounds, a ceramide, stylissamide A (1), and a cerebroside, stylissoside A (2), from the methanol extract of the Red Sea sponge Stylissa carteri. Structure elucidation was achieved using spectroscopic techniques, including 1D and 2D NMR and HRMS. The bioactive extract's metabolomic profiling showed the existence of various secondary metabolites, mainly oleanane-type saponins, phenolic diterpenes, and lupane triterpenes. The in vitro cytotoxic activity of the isolated compounds was tested against two human cancer cell lines, MCF-7 and HepG2. Both compounds, 1 and 2, displayed strong cytotoxicity against the MCF-7 cell line, with IC\(_{50}\) values at 21.1 ± 0.17 µM and 27.5 ± 0.18 µM, respectively. They likewise showed a promising activity against HepG2 with IC\(_{50}\) at 36.8 ± 0.16 µM for 1 and IC\(_{50}\) 30.5 ± 0.23 µM for 2 compared to the standard drug cisplatin. Molecular docking experiments showed that 1 and 2 displayed high affinity to the SET protein and to inhibitor 2 of protein phosphatase 2A (I2PP2A), which could be a possible mechanism for their cytotoxic activity. This paper spreads light on the role of these metabolites in holding fouling organisms away from the outer surface of the sponge, and the potential use of these defensive molecules in the production of novel anticancer agents.},
  language  = {en}
}
@article{AlnusaireSayedElmaidomyetal.2021,
  author    = {Alnusaire, Taghreed S. and Sayed, Ahmed M. and Elmaidomy, Abeer H. and Al-Sanea, Mohammad M. and Albogami, Sarah and Albqmi, Mha and Alowaiesh, Bassam F. and Mostafa, Ehab M. and Musa, Arafa and Youssif, Khayrya A. and Refaat, Hesham and Othman, Eman M. and Dandekar, Thomas and Alaaeldin, Eman and Ghoneim, Mohammed M. and Abdelmohsen, Usama Ramadan},
  title     = {An in vitro and in silico study of the enhanced antiproliferative and pro-oxidant potential of Olea europaea L. cv. Arbosana leaf extract via elastic nanovesicles (spanlastics)},
  series = {Antioxidants},
  volume    = {10},
  journal   = {Antioxidants},
  number    = {12},
  issn      = {2076-3921},
  doi       = {10.3390/antiox10121860},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-250064},
  year      = {2021},
  abstract  = {The olive tree is a venerable Mediterranean plant and often used in traditional medicine. The main aim of the present study was to evaluate the effect of Olea europaea L. cv. Arbosana leaf extract (OLE) and its encapsulation within a spanlastic dosage form on the improvement of its pro-oxidant and antiproliferative activity against HepG-2, MCF-7, and Caco-2 human cancer cell lines. The LC-HRESIMS-assisted metabolomic profile of OLE putatively annotated 20 major metabolites and showed considerable in vitro antiproliferative activity against HepG-2, MCF-7, and Caco-2 cell lines with IC\(_{50}\) values of 9.2 ± 0.8, 7.1 ± 0.9, and 6.5 ± 0.7 µg/mL, respectively. The encapsulation of OLE within a (spanlastic) nanocarrier system, using a spraying method and Span 40 and Tween 80 (4:1 molar ratio), was successfully carried out (size 41 ± 2.4 nm, zeta potential 13.6 ± 2.5, and EE 61.43 ± 2.03\%). OLE showed enhanced thermal stability, and an improved in vitro antiproliferative effect against HepG-2, MCF-7, and Caco-2 (IC\(_{50}\) 3.6 ± 0.2, 2.3 ± 0.1, and 1.8 ± 0.1 µg/mL, respectively) in comparison to the unprocessed extract. Both preparations were found to exhibit pro-oxidant potential inside the cancer cells, through the potential inhibitory activity of OLE against glutathione reductase and superoxide dismutase (IC\(_{50}\) 1.18 ± 0.12 and 2.33 ± 0.19 µg/mL, respectively). These inhibitory activities were proposed via a comprehensive in silico study to be linked to the presence of certain compounds in OLE. Consequently, we assume that formulating such a herbal extract within a suitable nanocarrier would be a promising improvement of its therapeutic potential.},
  language  = {en}
}
@article{AlWarhiElmaidomyMaheretal.2022,
  author    = {Al-Warhi, Tarfah and Elmaidomy, Abeer H. and Maher, Sherif A. and Abu-Baih, Dalia H. and Selim, Samy and Albqmi, Mha and Al-Sanea, Mohammad M. and Alnusaire, Taghreed S. and Ghoneim, Mohammed M. and Mostafa, Ehab M. and Hussein, Shaimaa and El-Damasy, Ashraf K. and Saber, Entesar Ali and Elrehany, Mahmoud A. and Sayed, Ahmed M. and Othman, Eman M. and El-Sherbiny, Mohamed and Abdelmohsen, Usama Ramadan},
  title     = {The wound-healing potential of Olea europaea L. Cv. Arbequina leaves extract: an integrated in vitro, in silico, and in vivo investigation},
  series = {Metabolites},
  volume    = {12},
  journal   = {Metabolites},
  number    = {9},
  issn      = {2218-1989},
  doi       = {10.3390/metabo12090791},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-286150},
  year      = {2022},
  abstract  = {Olea europaea L. Cv. Arbequina (OEA) (Oleaceae) is an olive variety species that has received little attention. Besides our previous work for the chemical profiling of OEA leaves using LC-HRESIMS, an additional 23 compounds are identified. An excision wound model is used to measure wound healing action. Wounds are provided with OEA (2\% w/v) or MEBO\(^®\) cream (marketed treatment). The wound closure rate related to vehicle-treated wounds is significantly increased by OEA. Comparing to vehicle wound tissues, significant levels of TGF-β in OEA and MEBO\(^®\) (p < 0.05) are displayed by gene expression patterns, with the most significant levels in OEA-treated wounds. Proinflammatory TNF-α and IL-1β levels are substantially reduced in OEA-treated wounds. The capability of several lignan-related compounds to interact with MMP-1 is revealed by extensive in silico investigation of the major OEA compounds (i.e., inverse docking, molecular dynamics simulation, and ΔG calculation), and their role in the wound-healing process is also characterized. The potential of OEA as a potent MMP-1 inhibitor is shown in subsequent in vitro testing (IC\(_{50}\) = 88.0 ± 0.1 nM). In conclusion, OEA is introduced as an interesting therapeutic candidate that can effectively manage wound healing because of its anti-inflammatory and antioxidant properties.},
  language  = {en}
}